BIOMAT Database Logo BIOMAT Database Logo

Anticoagulant effect of sodium cephalothin (Keflin). 1969

G Raccuglia, and N G Waterman

UI MeSH Term Description Entries
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D002512 Cephalothin A cephalosporin antibiotic. Cefalotin,Sodium Cephalothin,Cefalotina Normon,Cefalotina Sodica Spaly,Ceftina,Cephalothin Monosodium Salt,Keflin,Seffin,Cephalothin, Sodium,Monosodium Salt, Cephalothin,Salt, Cephalothin Monosodium
D005165 Factor V Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. Coagulation Factor V,Proaccelerin,AC Globulin,Blood Coagulation Factor V,Factor 5,Factor Five,Factor Pi,Factor V, Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Raccuglia, and N G Waterman
Cephalothin (Keflin).
January 1965, The Medical letter on drugs and therapeutics,
G Raccuglia, and N G Waterman
Evaluation of a new antibiotic. Sodium cephalothin (Keflin).
October 1965, JAMA,
G Raccuglia, and N G Waterman
[Comparative clinico-pharmacologic evaluation of cephalothin (Keflin)].
November 1973, Acta pharmaceutica Hungarica,
G Raccuglia, and N G Waterman
[On intraperitoneal administration of sodium cephalothin (Keflin "Shionogi"). On safety of administration under anesthesia].
February 1975, The Japanese journal of antibiotics,
G Raccuglia, and N G Waterman
The use of cephalothin sodium (keflin) as the prophylactic antibiotic for open heart surgery.
July 1977, The Journal of antimicrobial chemotherapy,
G Raccuglia, and N G Waterman
CRYSTALLOGRAPHY OF CEPHALOTHIN SODIUM.
October 1963, Journal of pharmaceutical sciences,
G Raccuglia, and N G Waterman
[Anticoagulant effect of sodium hexametaphosphate].
April 1952, Bollettino della Societa italiana di biologia sperimentale,
G Raccuglia, and N G Waterman
Thrombocytopenia with sodium cephalothin therapy.
September 1972, Annals of internal medicine,
G Raccuglia, and N G Waterman
An evaluation of intraperitoneal sodium cephalothin.
July 1967, Connecticut medicine,
G Raccuglia, and N G Waterman
Letter: Inline filtration of sodium cephalothin solutions.
November 1975, American journal of hospital pharmacy,
Copied contents to your clipboard!